Candriam S.C.A. Raises Holdings in Intuitive Surgical, Inc. $ISRG

Key Points

• Candriam S.C.A. increased its stake in Intuitive Surgical by 41.3%, owning 349,931 shares worth approximately $173.31 million.
• Analysts have mixed views on Intuitive Surgical, with a majority assigning it a 'Moderate Buy' rating, while Deutsche Bank recently downgraded it from 'hold' to 'sell'.
• Intuitive Surgical reported Q2 earnings of $2.19 per share, exceeding estimates of $1.93, with revenues hitting $2.44 billion, a year-over-year increase of 21.4%.

Candriam S.C.A. lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 41.3% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 349,931 shares of the medical equipment provider's stock after acquiring an additional 102,304 shares during the quarter. Intuitive Surgical makes up approximately 1.1% of Candriam S.C.A.'s holdings, making the stock its 18th biggest holding. Candriam S.C.A. owned about 0.10% of Intuitive Surgical worth $173,311,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of ISRG. Castleark Management LLC raised its holdings in shares of Intuitive Surgical by 3.4% in the 4th quarter. Castleark Management LLC now owns 90,469 shares of the medical equipment provider's stock valued at $47,221,000 after purchasing an additional 2,990 shares in the last quarter. Arlington Trust Co LLC boosted its stake in shares of Intuitive Surgical by 34.5% during the first quarter. Arlington Trust Co LLC now owns 745 shares of the medical equipment provider's stock valued at $369,000 after purchasing an additional 191 shares in the last quarter. Aveo Capital Partners LLC increased its holdings in Intuitive Surgical by 37.4% during the first quarter. Aveo Capital Partners LLC now owns 727 shares of the medical equipment provider's stock valued at $390,000 after buying an additional 198 shares during the period. Aaron Wealth Advisors LLC raised its stake in Intuitive Surgical by 3.2% in the first quarter. Aaron Wealth Advisors LLC now owns 2,509 shares of the medical equipment provider's stock worth $1,243,000 after buying an additional 78 shares in the last quarter. Finally, Longbow Finance SA raised its stake in Intuitive Surgical by 132.0% in the first quarter. Longbow Finance SA now owns 19,699 shares of the medical equipment provider's stock worth $9,756,000 after buying an additional 11,209 shares in the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Stock Performance

ISRG traded up $6.28 during trading on Friday, hitting $476.16. The stock had a trading volume of 2,023,902 shares, compared to its average volume of 1,973,062. The company has a market capitalization of $170.69 billion, a PE ratio of 66.41, a PEG ratio of 4.92 and a beta of 1.59. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $616.00. The stock has a 50 day simple moving average of $504.42 and a two-hundred day simple moving average of $522.06.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, beating the consensus estimate of $1.93 by $0.26. The company had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. Intuitive Surgical's revenue was up 21.4% compared to the same quarter last year. During the same period last year, the firm earned $1.78 earnings per share. On average, equities research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Activity

In other news, EVP Myriam Curet sold 4,500 shares of the business's stock in a transaction on Friday, July 25th. The shares were sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the sale, the executive vice president directly owned 353 shares of the company's stock, valued at $173,845.44. The trade was a 92.73% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Gary S. Guthart sold 2,800 shares of the business's stock in a transaction on Monday, July 28th. The shares were sold at an average price of $495.24, for a total transaction of $1,386,672.00. Following the sale, the insider directly owned 18,520 shares in the company, valued at $9,171,844.80. This trade represents a 13.13% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 15,839 shares of company stock valued at $7,896,972 over the last ninety days. 0.70% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

Several analysts have issued reports on the company. Citigroup reaffirmed a "buy" rating and set a $650.00 target price (up previously from $590.00) on shares of Intuitive Surgical in a research report on Thursday, May 22nd. Piper Sandler reaffirmed an "overweight" rating and set a $595.00 price objective (up previously from $575.00) on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Royal Bank Of Canada reiterated an "outperform" rating and issued a $615.00 target price on shares of Intuitive Surgical in a research note on Tuesday. Evercore ISI boosted their target price on shares of Intuitive Surgical from $470.00 to $550.00 and gave the stock an "in-line" rating in a report on Tuesday, July 8th. Finally, UBS Group increased their price target on shares of Intuitive Surgical from $547.00 to $585.00 and gave the company a "neutral" rating in a research report on Wednesday, July 23rd. Thirteen research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $595.95.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.